Internal Medicine · Sylacauga, AL
NPI
1093725624
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
209 W Spring St, Suite 200
Sylacauga, AL, 35150
Phone (256) 245-5241
Groups this clinician bills Medicare through
Medicare paid, 2024
$71K
1,679 services
Medicare patients, 2024
288
Average age 75
Drug cost, 2024
$3.4M
25,603 prescriptions
Company payments, 2025
$331
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Imad Khdair was code 99213 (office e&m - established), 389 times for 180 patients. In total Imad Khdair billed 1,679 services in 55 codes, and Medicare paid $71K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-10-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 389 | 180 | $52.05 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 372 | 167 | $10.76 | $4,004 |
| 99232 Hospital E&M - Subsequent | Facility | 139 | 69 | $56.47 | $7,849 |
| 99222 Hospital E&M - Initial | Facility | 51 | 43 | $90.07 | $4,594 |
| 99214 Office E&M - Established | Office | 50 | 45 | $82.36 | $4,118 |
| 99238 Hospital Discharge Management | Facility | 49 | 40 | $56.70 | $2,779 |
| 99212 Office E&M - Established | Office | 45 | 34 | $37.05 | $1,667 |
| 99231 Hospital E&M - Subsequent | Facility | 43 | 32 | $35.95 | $1,546 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 38 | 38 | $23.07 | $877 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 34 | 34 | $117.29 | $3,988 |
| G0008 Administration of influenza virus vaccine | Office | 32 | 32 | $29.46 | $943 |
| 90662 Vaccine Product | Office | 31 | 31 | $81.82 | $2,536 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 21 | 21 | $23.04 | $484 |
| 0241U Infectious Agent Detection by DNA/RNA | Office | 20 | 18 | $119.06 | $2,381 |
| G0513 Prolonged preventive service(s) (beyond the typical service time of the primary procedure), in the office or other outpatient setting requiring direct patient contact beyond the usual service; first 30 minutes (list separately in addition to code for preve | Office | 20 | 20 | $57.34 | $1,147 |
By year: 2022 $79K for 1,519 services; 2023 $73K for 1,384 services; 2024 $71K for 1,679 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 0241U Infectious Agent Detection by DNA/RNA | 20 | 18 | $119.06 | $2,381 |
Medicare prescription drug claims, 2024
In 2024, the drug Imad Khdair prescribed most often to Medicare patients was Amlodipine Besylate, with 811 prescriptions and refills. In total Imad Khdair wrote 25,603 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 811 | 2,182 | 244 | $5,459 |
| Atorvastatin Calcium Generic | 793 | 2,157 | 239 | $8,804 |
| Levothyroxine Sodium Generic | 654 | 1,417 | 144 | $6,213 |
| Pantoprazole Sodium Generic | 565 | 1,415 | 163 | $6,679 |
| Mounjaro Tirzepatide | 523 | 600 | 82 | $641K |
| Gabapentin Generic | 518 | 796 | 121 | $7,943 |
| Carvedilol Generic | 475 | 1,272 | 134 | $4,305 |
| Fluticasone Propionate Generic | 449 | 627 | 167 | $7,532 |
| Azithromycin Generic | 438 | 438 | 277 | $2,184 |
| Alprazolam Generic | 431 | 451 | 64 | $1,216 |
| Cyclobenzaprine Hcl Generic | 419 | 491 | 123 | $6,057 |
| Famotidine Generic | 403 | 880 | 110 | $8,250 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 395 | 479 | 119 | $8,147 |
| Ozempic Semaglutide | 389 | 531 | 77 | $514K |
| Hydralazine Hcl Generic | 377 | 868 | 106 | $3,511 |
Brand drugs: 4,145 claims; generic drugs: 21,137 claims; opioid claims: 849.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Imad Khdair $331 ($331 in general payments such as food, travel and fees) from 9 companies. The largest payer was Corcept Therapeutics with $70.91.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 3 | $70.91 |
| Ardelyx, Inc. ARDX | 3 | $66.79 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $53.82 |
| GlaxoSmithKline, LLC. GSK | 3 | $51.4 |
| Dexcom, Inc. DXCM | 1 | $22.35 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 1 | $19.11 |
| Novo Nordisk Inc NVO | 1 | $17.74 |
| Amgen Inc. AMGN | 1 | $14.92 |
| Pfizer Inc. PFE | 1 | $14.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.